Adalimumab-adbm Subcutaneous and Indacaterol Maleate

• Generic Name: adalimumab
• Dosage Forms: n.a.
• Other Brand Names: Humira, Humira Pen, Humira Pen Crohns/UlcerColit/HidraSuppur, Humira Pen Psoriasis/Uveitis Starter Package, Humira Pediatric, Humira Pediatric Crohn's Disease Starter Pack, Humira Pre-Filled Syringe, Humira Pen Psoriasis/Uveitis/Adol HidraSuppur Starter Pack, Humira Pen Crohns/Ulcer Colitis/Hidradenitis Suppurati StrPk

Adalimumab-adbm injection is used to treat the symptoms and prevent the progression of moderate to severely active rheumatoid arthritis and active ankylosing spondylitis. It is used in children 4 years of age and older for juvenile idiopathic arthritis. Adalimumab-adbm is also used to treat psoriatic arthritis, which is a type of arthritis that causes pain and swelling in the joints along with patches of scaly skin on some areas of the body. Psoriatic arthritis usually occurs with a skin condition called psoriasis. Adalimumab-adbm may be used alone or in combination with other medicines (eg, methotrexate).

Adalimumab-adbm injection is also used to treat the symptoms of active Crohn's disease in adult patients who have not been helped by other medicines, including infliximab. It is also used to treat moderate to moderate to severe ulcerative colitis in patients who have been treated with other medicines (eg, azathioprine, corticosteroids, or 6-mercaptopurine) that did not work well.

Adalimumab-adbm injection may also be used to treat chronic plaque psoriasis, which is a skin disease with red patches and white scales that do not go away.

Adalimumab-adbm is available only with your doctor's prescription.

• Generic Name: indacaterol
• Dosage Forms: n.a.
• Other Brand Names: Arcapta Neohaler

Long-term maintenance treatment of airflow obstruction associated with COPD, including chronic bronchitis and/or emphysema.

Not indicated for treatment of acute deterioration of COPD or relief of acute symptoms (i.e., as rescue therapy for treatment of acute episodes of bronchospasm). (See Deterioration of Disease and Acute Episodes under Cautions.)

Not indicated for treatment of asthma; safety and efficacy in asthma not established.